Hydroxyethyl starch 130/0.4 (6%)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Hydroxyethyl starch 130/0.4 (6%), covering 2012-06-26 to 2014-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Impact of %6 HES 130/0.4 and %4 Gelofusine Infusion on Kidney Function in the Living-donor Liver Transplantation